Pharmaceutical & medical devices Industry is fast adapting to these changes at various levels of the value chain. Billions of dollars are being spent on digital transformation projects ranging from usage of AI & ML in product development, production and predictive maintenance, Blockchain in supply chain and data management & analytics in strategic decision making. This article focuses on Omnichannel marketing, one of the key digital transformations that the industry is learning and implementing at a rapid pace. Omnichannel Marketing: Promise and Possibilities An industry that historically focused all their brand building and market shaping efforts through F2F meetings & medical education programs has started making giant strides in multi-channel strategy now. A digital journey that started with an e-detailing platform has progressed fast by adding brand websites, Approved E-Mails, social media, webinars and other media effectively creating a multi-channel strategy. The only hindside to this is, all these channels work independently, expecting HCPs to find and sort out information themselves.

“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale” - Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi

The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

The September 2016 Issue of MedicinMan features articles by Vivek Hattangadi, K. Hariram, Preeti Mohile, Mrudul Kansara and Chandan Kumar on topics such as The Entrepreneurial Mindset for Pharma Sales Professionals, Rural Marketing Challenges and Opportunities, the #Finding60InIndia Campaign to identify Progeria sufferers and more.

The PE Playbook: Why Private Equity is the New...

Tez Health and the New Race to Bring Healthcare...

The pharmaceutical industry stands at a critical juncture in...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

The PE Playbook: Why Private Equity is the New...

Tez Health and the New Race to Bring Healthcare...

The pharmaceutical industry stands at a critical juncture in...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

The PE Playbook: Why Private Equity is the New...

Tez Health and the New Race to Bring Healthcare...

The pharmaceutical industry stands at a critical juncture in...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

The PE Playbook: Why Private Equity is the New...

Tez Health and the New Race to Bring Healthcare...

The pharmaceutical industry stands at a critical juncture in...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...